Collectively, functional decline of the SIRT1–PGC-1α–NRF1/2–TFAM axis constitutes a central event underlying mitochondrial biogenic failure in sarcopenia and represents a promising therapeutic target. Here, PPARGC1A is linked to sarcopenia.